Keros Therapeutics, Inc.

NEW YORK STATE COMMON RETIREMENT FUND KROS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

10,616

Value ($000)

216

Weight

0.0%

2020 Q2 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	216	0.0%	10,616	12/31/2025
2025 Q3	11/3/2025	168	0.0%	10,616	9/30/2025
2025 Q2	10/8/2025	142	0.0%	10,616	6/30/2025
2025 Q1	10/8/2025	30	0.0%	2,916	3/31/2025
2024 Q4	10/8/2025	163	0.0%	10,316	12/31/2024
2024 Q3	10/8/2025	599	0.0%	10,316	9/30/2024
2024 Q2	10/8/2025	577	0.0%	12,616	6/30/2024
2024 Q1	10/8/2025	1,133	0.0%	17,122	3/31/2024
2023 Q4	10/8/2025	409	0.0%	10,293	12/31/2023
2023 Q3	10/8/2025	330	0.0%	10,337	9/30/2023
2023 Q2	10/8/2025	412	0.0%	10,245	6/30/2023
2023 Q1	10/8/2025	430	0.0%	10,067	3/31/2023
2022 Q4	10/8/2025	627	0.0%	13,052	12/31/2022
2022 Q3	11/8/2022	472	0.0%	12,559	9/30/2022
2022 Q2	8/4/2022	304	0.0%	11,014	6/30/2022
2022 Q1	7/1/2022	600	0.0%	11,037	3/31/2022
2021 Q4	2/2/2022	645	0.0%	11,027	12/31/2021
2021 Q3	11/2/2021	437	0.0%	11,058	9/30/2021
2021 Q2	8/2/2021	607	0.0%	14,302	6/30/2021
2021 Q1	5/11/2021	732	0.0%	11,900	3/31/2021
2020 Q4	2/8/2021	783	0.0%	11,100	12/31/2020
2020 Q3	11/5/2020	247	0.0%	6,400	9/30/2020
2020 Q2	8/7/2020	240	0.0%	6,400	6/30/2020